MedPath

A Study of Pain Relief in Low Back Pain

Phase 3
Completed
Conditions
Chronic Low Back Pain
Interventions
Drug: hydrocodone/acetaminophen extended release (Vicodin CR)
Drug: placebo
Registration Number
NCT00325949
Lead Sponsor
Abbott
Brief Summary

This is a study of the safety and pain-relieving ability of extended release hydrocodone and acetaminophen tablets in patients with moderate to severe low back pain

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
770
Inclusion Criteria
  • Males and females, ages 21-75 years
  • If female, must be of non-child bearing potential or practicing birth control
  • Has a history of chronic low back pain for at least 6 months
  • Requires medication for the management of the chronic low back pain
  • Has sufficient pain to justify the use of around-the-clock opioids
Exclusion Criteria
  • Is associated with any currently ongoing research study, or has previously participated in a Vicodin CR study
  • Is allergic or has had a serious reaction to hydrocodone, other opioids, or acetaminophen
  • Cannot discontinue pain medications, even for the short time prior to the study start
  • Has any clinically significant illness or recent injury, or has any significant laboratory abnormality, or has recently had major surgery, or plans to have surgery
  • Has a history of gastric bypass surgery or preexisting gastrointestinal narrowing, or history of diseases that may narrow the gastrointestinal tract
  • Has a history of malnutrition or starvation
  • Has a history of drug (licit or illicit) or alcohol abuse or addiction, or consumes more than 4 alcoholic drinks per day
  • Has a history of a major depressive episode within the past 2 years, or requires treatment with certain drugs for depression, or has a history of major psychiatric disorder
  • Is a pregnant or breastfeeding woman
  • Is incapacitated, bedridden, or confined to a wheelchair
  • Has initiated any new therapy or medication for chronic low back pain within 1 month of screening
  • Has had surgery, certain types of low back procedures, injured, or received certain medications for chronic low back pain within a certain specified time frame
  • Has back pain due to or associated with certain types of conditions
  • Has other conditions that may cause pain, such as rheumatoid arthritis, gout, or fibromyalgia

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
arm label (1) hydrocodone/acetaminophen extended releaseExtended release hydrocodone and acetaminophen (Vicodin CR)-
arm label (2) hydrocodone/acetaminophen extended releasehydrocodone/acetaminophen extended release (Vicodin CR)-
Arm label (3) placeboplacebo-
Primary Outcome Measures
NameTimeMethod
Pain Intensity Difference from randomization baseline to each subject's final assessment12 Weeks

Pain intensity difference assessed by the Chronic Low Back Pain Intensity Score (100mm Visual Analog Scale)

Secondary Outcome Measures
NameTimeMethod
Time to withdrawal due to lack of efficacy during the Double-blind Maintenance Period
Pain Intensity Difference from randomization baseline to each scheduled assessment
Global Assessments of Study Drug and Back Pain Status
Roland-Morris Disability Questionnaire

Trial Locations

Locations (63)

Site Ref # / Investigator 1982

🇺🇸

Missoula, Montana, United States

Site Ref # / Investigator 2204

🇺🇸

Miami, Florida, United States

Site Ref # / Investigator 2205

🇺🇸

Miami, Florida, United States

Site Ref # / Investigator 1988

🇺🇸

West Des Moines, Iowa, United States

Site Ref # / Investigator 2607

🇺🇸

Bulverde, Texas, United States

Site Ref # / Investigator 2604

🇺🇸

Nederland, Texas, United States

Site Ref # / Investigator 2580

🇺🇸

Prairie Village, Kansas, United States

Site Ref # / Investigator 2605

🇺🇸

Phoenix, Arizona, United States

Site Ref # / Investigator 1990

🇺🇸

Phoenix, Arizona, United States

Site Ref # / Investigator 3421

🇺🇸

Las Vegas, Nevada, United States

Site Ref # / Investigator 2206

🇺🇸

Las Vegas, Nevada, United States

Site Ref # / Investigator 2218

🇺🇸

Cincinnati, Ohio, United States

Site Ref # / Investigator 2211

🇺🇸

Oklahoma City, Oklahoma, United States

Site Ref # / Investigator 1981

🇺🇸

San Antonio, Texas, United States

Site Ref # / Investigator 2608

🇺🇸

San Antonio, Texas, United States

Site Ref # / Investigator 2157

🇺🇸

Denver, Colorado, United States

Site Ref # / Investigator 1986

🇺🇸

Omaha, Nebraska, United States

Site Ref # / Investigator 1992

🇺🇸

Buena Park, California, United States

Site Ref # / Investigator 2216

🇺🇸

Hueytown, Alabama, United States

Site Ref # / Investigator 1993

🇺🇸

Burbank, California, United States

Site Ref # / Investigator 1989

🇺🇸

Los Gatos, California, United States

Site Ref # / Investigator 2219

🇺🇸

Fair Oaks, California, United States

Site Ref # / Investigator 2214

🇺🇸

Oldsmar, Florida, United States

Site Ref # / Investigator 2135

🇺🇸

Plantation, Florida, United States

Site Ref # / Investigator 1975

🇺🇸

Atlanta, Georgia, United States

Site Ref # / Investigator 1991

🇺🇸

Decatur, Georgia, United States

Site Ref # / Investigator 1985

🇺🇸

Chicago, Illinois, United States

Site Ref # / Investigator 1978

🇺🇸

Evansville, Indiana, United States

Site Ref # / Investigator 1976

🇺🇸

Shreveport, Louisiana, United States

Site Ref # / Investigator 2209

🇺🇸

Metairie, Louisiana, United States

Site Ref # / Investigator 2556

🇺🇸

Florissant, Missouri, United States

Site Ref # / Investigator 1980

🇺🇸

St. Louis, Missouri, United States

Site Ref # / Investigator 1983

🇺🇸

Raleigh, North Carolina, United States

Site Ref # / Investigator 2578

🇺🇸

Williamsville, New York, United States

Site Ref # / Investigator 2606

🇺🇸

Raleigh, North Carolina, United States

Site Ref # / Investigator 1973

🇺🇸

New York, New York, United States

Site Ref # / Investigator 1995

🇺🇸

Cincinnati, Ohio, United States

Site Ref # / Investigator 1987

🇺🇸

Cincinnati, Ohio, United States

Site Ref # / Investigator 2215

🇺🇸

Downingtown, Pennsylvania, United States

Site Ref # / Investigator 2579

🇺🇸

Duncansville, Pennsylvania, United States

Site Ref # / Investigator 2137

🇺🇸

Cranston, Rhode Island, United States

Site Ref # / Investigator 2213

🇺🇸

Mechanicsburg, Pennsylvania, United States

Site Ref # / Investigator 2590

🇺🇸

Dallas, Texas, United States

Site Ref # / Investigator 2217

🇺🇸

Austin, Texas, United States

Site Ref # / Investigator 2117

🇺🇸

Killeen, Texas, United States

Site Ref # / Investigator 1979

🇺🇸

Richardson, Texas, United States

Site Ref # / Investigator 2220

🇺🇸

San Antonio, Texas, United States

Site Ref # / Investigator 2212

🇺🇸

San Angelo, Texas, United States

Site Ref # / Investigator 2158

🇺🇸

Virginia Beach, Virginia, United States

Site Ref # / Investigator 5161

🇺🇸

Winston-Salem, North Carolina, United States

Site Ref # / Investigator 2603

🇺🇸

Brockton, Massachusetts, United States

Site Ref # / Investigator 1974

🇺🇸

Tempe, Arizona, United States

Site Ref # / Investigator 2208

🇺🇸

Clearwater, Florida, United States

Site Ref # / Investigator 2221

🇺🇸

Greer, South Carolina, United States

Site Ref # / Investigator 2207

🇺🇸

Hollywood, Florida, United States

Site Ref # / Investigator 2156

🇺🇸

Wellesley Hills, Massachusetts, United States

Site Ref # / Investigator 3420

🇺🇸

Biloxi, Mississippi, United States

Site Ref # / Investigator 1984

🇺🇸

Cordova, Tennessee, United States

Site Ref # / Investigator 2134

🇺🇸

West Palm Beach, Florida, United States

Site Ref # / Investigator 1977

🇺🇸

Tucson, Arizona, United States

Site Ref # / Investigator 1994

🇺🇸

Trumbull, Connecticut, United States

Site Ref # / Investigator 2210

🇺🇸

DeLand, Florida, United States

Site Ref # / Investigator 2203

🇺🇸

Pasadena, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath